• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.48% Nasdaq Up0.40%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    16.17 Down 0.31(1.85%) 3:35PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 767   123   -  
    Cost of Revenue333  108   -  
    Gross Profit 434   15   -  
    Operating Expenses
    Research Development19,985  10,925  7,291  
    Selling General and Administrative17,938  8,572  2,987  
    Non Recurring2,229  1  1,500  
    Others1,891  298   -  
    Total Operating Expenses42,043  19,796   -  
    Operating Income or Loss (41,609) (19,781) (11,778)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,410  553  142  
    Earnings Before Interest And Taxes(39,199)(19,228)(11,636)
    Interest Expense1,060  432   -  
    Income Before Tax(40,259)(19,660)(11,636)
    Income Tax Expense(1,443)(12,722) -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(38,816)(6,938)(11,636)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (38,816) (6,938) (11,636)
    Preferred Stock And Other Adjustments -   -  (2,035)
    Net Income Applicable To Common Shares (38,816) (6,938) (13,671)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.